Acadia Pharmaceuticals Inc ACAD

NAS: ACAD | ISIN: US0042251084 17/09/2025

24,20 USD (+1,00%)

(+1,00%) 17/09/2025

Grafiek Acadia Pharmaceuticals Inc

Grafiek Acadia Pharmaceuticals Inc

1 dag1d 1,00%
1 week1w 0,00%
1 maand1m -3,43%
3 maanden3m 5,45%
6 maanden6m 40,05%
1 jaar1j 48,19%
5 jaar5j -42,95%

Acadia Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

12 november 2022 · ACADIA PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ACADIA Pharmaceuticals Inc. - ACAD · Persbericht

13 mei 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD) · Persbericht

22 april 2021 · ACAD Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies ACADIA Pharmaceuticals Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm · Persbericht

22 april 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Filed · Persbericht

6 april 2021 · Ademi LLP Investigates Claims of Securities Fraud against Acadia Pharmaceuticals Inc. · Persbericht

6 april 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys · Persbericht

10 maart 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys · Persbericht

Profiel Acadia Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.acadia-pharm.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe